0 XP   0   0   0

International Stem Cell Corp
Buy, Hold or Sell?

I guess you are interested in International Stem Cell Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse International Stem Cell Corp

Let's start. I'm going to help you getting a better view of International Stem Cell Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is International Stem Cell Corp even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how International Stem Cell Corp is doing in the market. If the company is worth buying. The latest step is to find out how other investors value International Stem Cell Corp. The closing price on 2022-10-03 was $0.37 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
International Stem Cell Corp Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

1.1. Profitability of International Stem Cell Corp.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit International Stem Cell Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • A Net Profit Margin of -0.1% means that $[indicator name=netProfitMargin&period=MRQ&percentage=1 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of International Stem Cell Corp:

  • The MRQ is -0.1%. The company is not making a profit/loss.
  • The TTM is -7.1%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM-7.1%+7.0%
TTM-7.1%YOY-27.5%+20.4%
TTM-7.1%5Y-32.9%+25.8%
5Y-32.9%10Y-35.4%+2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1%-256.4%+256.3%
TTM-7.1%-281.5%+274.4%
YOY-27.5%-344.8%+317.3%
5Y-32.9%-492.0%+459.1%
10Y-35.4%-561.7%+526.3%
1.1.2. Return on Assets

Shows how efficient International Stem Cell Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • 0.0% Return on Assets means that International Stem Cell Corp generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of International Stem Cell Corp:

  • The MRQ is 0.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-2.7%+2.6%
TTM-2.7%YOY-7.3%+4.6%
TTM-2.7%5Y-9.8%+7.1%
5Y-9.8%10Y-8.6%-1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%-9.9%+9.9%
TTM-2.7%-8.7%+6.0%
YOY-7.3%-9.3%+2.0%
5Y-9.8%-11.6%+1.8%
10Y-8.6%-12.3%+3.7%
1.1.3. Return on Equity

Shows how efficient International Stem Cell Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • 0.0% Return on Equity means International Stem Cell Corp generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of International Stem Cell Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-10.3%+10.3%
5Y-10.3%10Y-11.7%+1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.0%+12.0%
TTM--10.9%+10.9%
YOY--10.7%+10.7%
5Y-10.3%-13.8%+3.5%
10Y-11.7%-14.7%+3.0%

1.2. Operating Efficiency of International Stem Cell Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient International Stem Cell Corp is operating .

  • Measures how much profit International Stem Cell Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare International Stem Cell Corp to the Biotechnology industry mean.
  • An Operating Margin of 1.5% means the company generated $0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of International Stem Cell Corp:

  • The MRQ is 1.5%. The company is operating less efficient.
  • The TTM is -12.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ1.5%TTM-12.1%+13.7%
TTM-12.1%YOY-25.5%+13.4%
TTM-12.1%5Y-30.8%+18.7%
5Y-30.8%10Y-35.3%+4.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%-232.1%+233.6%
TTM-12.1%-266.2%+254.1%
YOY-25.5%-311.8%+286.3%
5Y-30.8%-472.5%+441.7%
10Y-35.3%-560.3%+525.0%
1.2.2. Operating Ratio

Measures how efficient International Stem Cell Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are $1.34 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of International Stem Cell Corp:

  • The MRQ is 1.339. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.510. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.339TTM1.510-0.171
TTM1.510YOY1.400+0.110
TTM1.5105Y1.582-0.072
5Y1.58210Y1.251+0.331
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3393.270-1.931
TTM1.5103.490-1.980
YOY1.4003.442-2.042
5Y1.5825.620-4.038
10Y1.2516.585-5.334

1.3. Liquidity of International Stem Cell Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if International Stem Cell Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.64 means the company has $0.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of International Stem Cell Corp:

  • The MRQ is 0.638. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.592. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.638TTM0.592+0.045
TTM0.592YOY0.857-0.265
TTM0.5925Y0.769-0.177
5Y0.76910Y0.580+0.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6385.117-4.479
TTM0.5925.755-5.163
YOY0.8575.878-5.021
5Y0.7696.514-5.745
10Y0.5806.212-5.632
1.3.2. Quick Ratio

Measures if International Stem Cell Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 0.16 means the company can pay off $0.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of International Stem Cell Corp:

  • The MRQ is 0.158. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.174. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.158TTM0.174-0.016
TTM0.174YOY0.439-0.265
TTM0.1745Y0.349-0.175
5Y0.34910Y0.252+0.097
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1583.813-3.655
TTM0.1744.348-4.174
YOY0.4394.712-4.273
5Y0.3494.779-4.430
10Y0.2524.467-4.215

1.4. Solvency of International Stem Cell Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of International Stem Cell Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 1.82 means that International Stem Cell Corp assets are financed with 181.6% credit (debt) and the remaining percentage (100% - 181.6%) is financed by its owners/shareholders. -0.1%

Let's take a look of the Debt to Asset Ratio trends of International Stem Cell Corp:

  • The MRQ is 1.816. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.861. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.816TTM1.861-0.046
TTM1.861YOY1.000+0.861
TTM1.8615Y1.167+0.694
5Y1.16710Y0.986+0.182
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8160.274+1.542
TTM1.8610.274+1.587
YOY1.0000.304+0.696
5Y1.1670.366+0.801
10Y0.9860.400+0.586
1.4.2. Debt to Equity Ratio

Measures if International Stem Cell Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of International Stem Cell Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.797-0.797
5Y0.79710Y3.099-2.302
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.311-0.311
TTM-0.315-0.315
YOY-0.321-0.321
5Y0.7970.398+0.399
10Y3.0990.454+2.645

2. Market Valuation of International Stem Cell Corp

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in International Stem Cell Corp.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -6.23 means the investor is paying $-6.23 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of International Stem Cell Corp:

  • The EOD is -5.620. Company is losing money. -2
  • The MRQ is -6.227. Company is losing money. -2
  • The TTM is -6.456. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-5.620MRQ-6.227+0.608
MRQ-6.227TTM-6.456+0.228
TTM-6.456YOY-1.727-4.729
TTM-6.4565Y-2.984-3.471
5Y-2.98410Y-0.779-2.205
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.620-2.215-3.405
MRQ-6.227-2.524-3.703
TTM-6.456-4.050-2.406
YOY-1.727-5.007+3.280
5Y-2.984-3.850+0.866
10Y-0.779-3.475+2.696
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of International Stem Cell Corp.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of International Stem Cell Corp:

  • The MRQ is 0.089. Very good. +2
  • The TTM is 0.082. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.089TTM0.082+0.007
TTM0.082YOY0.039+0.044
TTM0.0825Y0.041+0.041
5Y0.04110Y0.011+0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0890.005+0.084
TTM0.0820.022+0.060
YOY0.0390.043-0.004
5Y0.0410.024+0.017
10Y0.0110.020-0.009

2. Books
2.3. Price to Book Ratio

Measures if the stock price of International Stem Cell Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.74 means the investor is paying $-0.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of International Stem Cell Corp:

  • The EOD is -0.670. Bad. Book ratio is negative. -2
  • The MRQ is -0.743. Bad. Book ratio is negative. -2
  • The TTM is -0.847. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-0.670MRQ-0.743+0.072
MRQ-0.743TTM-0.847+0.104
TTM-0.847YOY-155.951+155.104
TTM-0.8475Y-32.793+31.945
5Y-32.79310Y-15.469-17.324
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.6701.932-2.602
MRQ-0.7432.138-2.881
TTM-0.8472.946-3.793
YOY-155.9513.587-159.538
5Y-32.7932.909-35.702
10Y-15.4692.520-17.989

3. Summary

3.1. Key Performance Indicators

The key performance indicators of International Stem Cell Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share---0.552-0.558+1%-0.001-100%-0.084-85%-0.100-82%
Book Value Per Share Growth--0.011-0.138+1352%0.119-91%-0.047+532%-0.016+243%
Current Ratio--0.6380.592+8%0.857-26%0.769-17%0.580+10%
Debt To Asset Ratio--1.8161.861-2%1.000+81%1.167+56%0.986+84%
Debt To Equity Ratio----0%-0%0.797-100%3.099-100%
Dividend Per Share----0%-0%-0%-0%
Eps--0.000-0.016+6488%-0.055+21938%-0.107+42629%-5.345+2139064%
Eps Growth---70.108-75.227+7%-11.070-84%-197.172+181%-40.185-43%
Gains Per Share--0.011-0.138+1352%0.119-91%-0.047+532%-0.016+243%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.775+29%
Net Profit Margin---0.001-0.071+7133%-0.275+27760%-0.329+33243%-0.354+35779%
Operating Margin--0.015-0.121+894%-0.255+1769%-0.308+2116%-0.353+2409%
Operating Ratio--1.3391.510-11%1.400-4%1.582-15%1.251+7%
Pb Ratio-0.670+10%-0.743-0.847+14%-155.951+20894%-32.793+4315%-15.469+1982%
Pe Ratio-5.620+10%-6.227-6.456+4%-1.727-72%-2.984-52%-0.779-87%
Peg Ratio--0.0890.082+8%0.039+130%0.041+116%0.011+699%
Price Per Share0.370-11%0.4100.473-13%0.595-31%0.907-55%0.980-58%
Quick Ratio--0.1580.174-9%0.439-64%0.349-55%0.252-37%
Return On Assets--0.000-0.027+7103%-0.073+19558%-0.098+26321%-0.086+23105%
Return On Equity----0%-0%-0.1030%-0.1170%
 EOD+1 -2MRQTTM+12 -4YOY+7 -95Y+11 -610Y+11 -7

3.2. Fundamental Score

Let's check the fundamental score of International Stem Cell Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.620
Price to Book Ratio (EOD)Between0-1-0.670
Net Profit Margin (MRQ)Greater than0-0.001
Operating Margin (MRQ)Greater than00.015
Quick Ratio (MRQ)Greater than10.158
Current Ratio (MRQ)Greater than10.638
Debt to Asset Ratio (MRQ)Less than11.816
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of International Stem Cell Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.149
Ma 20Greater thanMa 500.355
Ma 50Greater thanMa 1000.386
Ma 100Greater thanMa 2000.417
OpenGreater thanClose0.370
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets5,416
Total Liabilities9,834
Total Stockholder Equity-4,418
 As reported
Total Liabilities 9,834
Total Stockholder Equity+ -4,418
Total Assets = 5,416

Assets

Total Assets5,416
Total Current Assets2,994
Long-term Assets2,994
Total Current Assets
Cash And Cash Equivalents 586
Net Receivables 743
Inventory 1,361
Other Current Assets 63
Total Current Assets  (as reported)2,994
Total Current Assets  (calculated)2,753
+/- 241
Long-term Assets
Property Plant Equipment 1,113
Intangible Assets 917
Other Assets 392
Long-term Assets  (as reported)2,422
Long-term Assets  (calculated)2,422
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,694
Long-term Liabilities5,140
Total Stockholder Equity-4,418
Total Current Liabilities
Short Long Term Debt 3,258
Accounts payable 477
Other Current Liabilities 250
Total Current Liabilities  (as reported)4,694
Total Current Liabilities  (calculated)3,985
+/- 709
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,048
Long-term Liabilities  (as reported)5,140
Long-term Liabilities  (calculated)1,048
+/- 4,092
Total Stockholder Equity
Common Stock8
Total Stockholder Equity (as reported)-4,418
Total Stockholder Equity (calculated)8
+/- 4,426
Other
Capital Stock13
Common Stock Shares Outstanding 8,004
Net Debt 2,672
Net Invested Capital -1,165
Net Tangible Assets -5,340
Net Working Capital -1,700



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-30
> Total Assets 
8,112
7,325
10,586
8,909
7,116
5,370
6,815
6,098
6,927
7,739
6,652
6,615
6,364
7,179
6,693
6,885
7,230
7,138
8,388
7,861
7,540
7,045
7,855
7,614
7,953
6,864
7,468
8,416
8,725
7,796
8,663
8,541
8,260
6,620
6,876
6,783
5,851
5,287
6,019
5,611
4,937
4,946
5,501
5,416
5,4165,5014,9464,9375,6116,0195,2875,8516,7836,8766,6208,2608,5418,6637,7968,7258,4167,4686,8647,9537,6147,8557,0457,5407,8618,3887,1387,2306,8856,6937,1796,3646,6156,6527,7396,9276,0986,8155,3707,1168,90910,5867,3258,112
   > Total Current Assets 
5,543
4,611
0
0
0
0
0
0
0
4,626
3,535
3,213
2,877
0
0
0
3,593
2,991
4,133
3,320
3,137
2,492
3,274
2,796
3,133
2,855
3,410
4,340
4,692
3,770
3,512
3,328
3,259
3,452
3,380
3,398
2,631
2,183
3,046
2,786
2,486
2,334
2,960
2,994
2,9942,9602,3342,4862,7863,0462,1832,6313,3983,3803,4523,2593,3283,5123,7704,6924,3403,4102,8553,1332,7963,2742,4923,1373,3204,1332,9913,5930002,8773,2133,5354,62600000004,6115,543
       Cash And Cash Equivalents 
3,582
2,584
6,013
4,285
2,380
654
1,912
654
1,792
2,293
1,041
798
521
1,111
611
554
599
532
1,542
768
733
110
676
297
510
304
447
477
1,161
1,075
615
595
463
484
708
1,315
1,026
689
1,117
750
505
171
398
586
5863981715057501,1176891,0261,3157084844635956151,0751,1614774473045102976761107337681,5425325995546111,1115217981,0412,2931,7926541,9126542,3804,2856,0132,5843,582
       Short-term Investments 
0
0
0
0
0
0
0
50
50
50
50
50
50
50
50
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000005050505050505050500000000
       Net Receivables 
342
246
0
0
0
0
0
0
0
306
501
406
464
0
0
0
615
539
461
518
595
574
615
605
684
465
939
1,614
1,545
651
957
976
1,080
1,515
1,138
694
509
403
437
547
668
844
902
743
7439028446685474374035096941,1381,5151,0809769576511,5451,6149394656846056155745955184615396150004644065013060000000246342
       Inventory 
1,329
1,497
1,228
1,272
1,122
1,199
1,206
1,370
1,360
1,369
1,357
1,470
1,533
1,517
1,668
1,759
1,874
1,348
1,434
1,368
1,284
1,390
1,423
1,390
1,352
1,307
1,385
1,682
1,474
1,501
1,460
1,317
1,409
1,246
1,100
1,010
937
917
1,055
1,073
1,139
1,184
1,322
1,361
1,3611,3221,1841,1391,0731,0559179371,0101,1001,2461,4091,3171,4601,5011,4741,6821,3851,3071,3521,3901,4231,3901,2841,3681,4341,3481,8741,7591,6681,5171,5331,4701,3571,3691,3601,3701,2061,1991,1221,2721,2281,4971,329
       Other Current Assets 
290
284
297
291
293
456
492
663
407
658
636
539
359
485
384
574
505
572
696
666
525
418
560
504
587
779
639
567
512
0
480
440
307
207
434
379
159
174
437
416
0
0
0
63
630004164371741593794342073074404800512567639779587504560418525666696572505574384485359539636658407663492456293291297284290
   > Long-term Assets 
2,569
2,713
0
0
0
0
0
0
0
3,113
3,117
3,402
3,487
0
0
0
3,637
4,147
4,255
4,541
4,403
4,553
4,581
4,818
4,119
3,317
3,339
3,358
3,259
0
4,359
5,213
5,001
3,168
3,496
3,385
2,837
2,733
2,589
2,462
2,451
2,612
2,541
2,422
2,4222,5412,6122,4512,4622,5892,7332,8373,3853,4963,1685,0015,2134,35903,2593,3583,3393,3174,1194,8184,5814,5534,4034,5414,2554,1473,6370003,4873,4023,1173,11300000002,7132,569
       Property Plant Equipment 
1,496
1,517
1,356
1,246
1,238
1,134
1,033
928
851
830
742
847
781
714
630
546
459
864
848
963
951
1,011
997
1,001
339
321
336
384
347
469
652
1,546
1,475
1,385
1,697
1,613
568
534
492
451
1,078
1,252
1,183
1,113
1,1131,1831,2521,0784514925345681,6131,6971,3851,4751,5466524693473843363213391,0019971,0119519638488644595466307147818477428308519281,0331,1341,2381,2461,3561,5171,496
       Intangible Assets 
1,057
1,180
1,419
1,589
1,652
1,634
1,768
1,947
2,036
2,250
2,342
2,522
2,649
2,795
2,863
2,980
3,121
3,223
3,344
3,520
3,394
3,484
3,526
3,760
3,706
2,922
2,928
2,910
2,848
2,674
2,700
2,790
2,691
1,335
1,351
1,345
1,266
1,262
1,242
1,228
962
949
933
917
9179339499621,2281,2421,2621,2661,3451,3511,3352,6912,7902,7002,6742,8482,9102,9282,9223,7063,7603,5263,4843,3943,5203,3443,2233,1212,9802,8632,7952,6492,5222,3422,2502,0361,9471,7681,6341,6521,5891,4191,1801,057
       Long-term Assets Other 
16
16
0
0
0
0
0
0
0
33
33
33
57
0
0
0
57
60
63
58
58
58
58
57
74
74
75
64
64
0
1,007
784
745
358
375
356
1,003
937
855
783
365
372
390
359
3593903723657838559371,0033563753587457841,0070646475747457585858586360570005733333300000001616
> Total Liabilities 
3,303
2,189
1,958
2,237
1,964
2,187
1,594
2,576
6,389
7,021
6,048
2,039
2,269
6,858
6,772
6,080
6,396
5,544
21,240
8,843
7,115
3,601
7,217
6,021
8,139
4,800
5,829
6,773
5,939
5,259
5,477
9,732
8,936
9,508
9,719
10,388
5,427
5,320
6,417
5,621
9,294
9,534
10,007
9,834
9,83410,0079,5349,2945,6216,4175,3205,42710,3889,7199,5088,9369,7325,4775,2595,9396,7735,8294,8008,1396,0217,2173,6017,1158,84321,2405,5446,3966,0806,7726,8582,2692,0396,0487,0216,3892,5761,5942,1871,9642,2371,9582,1893,303
   > Total Current Liabilities 
3,303
2,189
1,958
2,237
1,964
2,187
1,594
2,576
6,389
7,021
6,048
2,039
2,269
6,858
6,772
6,080
6,396
5,544
21,240
8,843
7,115
3,601
7,217
6,021
8,139
4,800
5,829
6,773
5,939
5,077
4,466
4,458
3,707
1,913
4,205
4,081
3,852
1,483
4,721
4,431
4,349
4,284
4,811
4,694
4,6944,8114,2844,3494,4314,7211,4833,8524,0814,2051,9133,7074,4584,4665,0775,9396,7735,8294,8008,1396,0217,2173,6017,1158,84321,2405,5446,3966,0806,7726,8582,2692,0396,0487,0216,3892,5761,5942,1871,9642,2371,9582,1893,303
       Short-term Debt 
0
0
0
0
0
0
0
0
0
4,925
4,302
0
0
0
0
0
1,354
239
19,616
7,148
5,419
2,045
4,077
2,493
3,667
3,113
2,758
2,779
2,021
0
1,148
837
0
0
0
0
0
0
0
0
0
0
0
0
0000000000008371,14802,0212,7792,7583,1133,6672,4934,0772,0455,4197,14819,6162391,354000004,3024,925000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
2,700
0
351
1,100
0
0
294
1,827
1,848
0
2,395
2,422
2,505
141
3,071
2,882
2,912
2,943
3,225
3,258
3,2583,2252,9432,9122,8823,0711412,5052,4222,39501,8481,827294001,10035102,7002,00000000000000000000000000
       Accounts payable 
1,888
1,287
719
995
1,056
969
430
743
522
1,843
1,496
1,789
2,019
670
1,765
580
4,792
5,055
1,374
1,445
1,446
1,306
2,890
3,278
4,222
1,437
2,821
3,744
3,668
458
2,774
731
722
654
534
579
3,213
746
3,924
3,872
611
508
635
477
4776355086113,8723,9247463,2135795346547227312,7744583,6683,7442,8211,4374,2223,2782,8901,3061,4461,4451,3745,0554,7925801,7656702,0191,7891,4961,8435227434309691,0569957191,2871,888
       Other Current Liabilities 
1,415
902
1,239
1,242
908
1,218
1,164
1,833
5,867
253
250
250
250
6,188
5,007
3,238
250
250
250
250
250
250
250
250
250
250
250
250
250
1,995
544
837
250
250
250
250
639
737
797
559
250
250
250
250
2502502502505597977376392502502502508375441,9952502502502502502502502502502502502502503,2385,0076,1882502502502535,8671,8331,1641,2189081,2421,2399021,415
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,011
5,274
5,229
7,595
5,514
6,307
1,575
3,837
1,696
1,190
4,945
5,250
5,196
5,140
5,1405,1965,2504,9451,1901,6963,8371,5756,3075,5147,5955,2295,2741,011000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
207
97
322
40
0
0
0
0
0
0
0
00000004032297207000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
4,941
4,941
4,941
4,941
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,300
4,300
4,300
4,300
4,300
4,300
4,300
4,300
4,300
0
0
0
0
00004,3004,3004,3004,3004,3004,3004,3004,3004,3000000000000000000004,9414,9414,9414,941000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
182
0
0
0
207
97
322
40
0
0
0
0
0
0
0
0000000403229720700018200000000000000000000000000000
> Total Stockholder Equity
4,809
5,136
8,628
6,672
5,152
3,183
5,221
3,522
538
-4,223
-4,337
-365
-846
321
0
805
834
1,594
-12,852
-982
425
3,444
638
1,593
-186
2,064
1,639
1,643
2,786
2,532
3,186
-1,191
-676
-2,888
-2,843
-3,605
-3,876
-4,333
-4,698
-4,310
-4,357
-4,588
-4,506
-4,418
-4,418-4,506-4,588-4,357-4,310-4,698-4,333-3,876-3,605-2,843-2,888-676-1,1913,1862,5322,7861,6431,6392,064-1861,5936383,444425-982-12,8521,5948348050321-846-365-4,337-4,2235383,5225,2213,1835,1526,6728,6285,1364,809
   Common Stock
77
79
87
87
87
87
112
113
134
151
157
214
224
239
262
274
2
3
3
3
4
4
4
4
4
6
6
6
7
7
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8888888888888877666444443332274262239224214157151134113112878787877977
   Retained Earnings Total Equity0000-109,498-109,714-109,115-108,394-107,850-106,764-106,391-103,677-103,680-107,5690-105,635-105,756-105,362-104,532-103,143-100,979-101,547-98,463-100,624-101,038-111,957-97,384-95,852000-90,150-88,116-83,706-82,2710000000-57,723-55,051
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000
   Capital Surplus 
59,780
62,777
0
0
0
0
0
0
0
77,897
79,212
87,537
89,080
0
0
0
96,679
98,970
99,097
100,048
101,040
101,898
102,176
102,563
102,948
106,585
106,990
107,388
108,409
0
110,742
102,476
102,988
103,490
103,908
104,232
104,505
104,769
105,003
105,175
0
0
0
0
0000105,175105,003104,769104,505104,232103,908103,490102,988102,476110,7420108,409107,388106,990106,585102,948102,563102,176101,898101,040100,04899,09798,97096,67900089,08087,53779,21277,897000000062,77759,780
   Treasury Stock00000000000000000000000000000000000000000000
   Other Stockholders Equity 00000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue7,176
Cost of Revenue-2,935
Gross Profit4,2414,241
 
Operating Income (+$)
Gross Profit4,241
Operating Expense-9,097
Operating Income-1,921-4,856
 
Operating Expense (+$)
Research Development695
Selling General Administrative5,467
Selling And Marketing Expenses-
Operating Expense9,0976,162
 
Net Interest Income (+$)
Interest Income-
Interest Expense-128
Net Interest Income-128-128
 
Pretax Income (+$)
Operating Income-1,921
Net Interest Income-128
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-899-3,071
EBIT - interestExpense = -1,799
-899
-771
Interest Expense128
Earnings Before Interest and Taxes (ebit)-1,671-771
Earnings Before Interest and Taxes (ebitda)-509
 
After tax Income (+$)
Income Before Tax-899
Tax Provision--
Net Income From Continuing Ops-899-899
Net Income-899
Net Income Applicable To Common Shares-899
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1,150128
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
C76.SG
26 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of C76.SG.

C76.SG Daily Candlestick Chart
CSM.VN
44 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CSM.VN.

CSM.VN Daily Candlestick Chart
VND.VN
46 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VND.VN.

VND.VN Daily Candlestick Chart
VNG.VN
46 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VNG.VN.

VNG.VN Daily Candlestick Chart
VCI.VN
46 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VCI.VN.

VCI.VN Daily Candlestick Chart
TPB.VN
46 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TPB.VN.

TPB.VN Daily Candlestick Chart
ST8.VN
46 minutes ago

I found you a Death Cross on the daily chart of ST8.VN.

ST8.VN Daily Candlestick Chart
STB.VN
46 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STB.VN.

STB.VN Daily Candlestick Chart
SJF.VN
46 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SJF.VN.

SJF.VN Daily Candlestick Chart
SBT.VN
46 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SBT.VN.

SBT.VN Daily Candlestick Chart
VIX.VN
46 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VIX.VN.

VIX.VN Daily Candlestick Chart
POW.VN
48 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of POW.VN.

POW.VN Daily Candlestick Chart
NVL.VN
48 minutes ago

I found you a Golden Cross on the daily chart of NVL.VN.

NVL.VN Daily Candlestick Chart
NTL.VN
48 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NTL.VN.

NTL.VN Daily Candlestick Chart
NKG.VN
48 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NKG.VN.

NKG.VN Daily Candlestick Chart
MWG.VN
48 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MWG.VN.

MWG.VN Daily Candlestick Chart
LDG.VN
49 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LDG.VN.

LDG.VN Daily Candlestick Chart
LCG.VN
49 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LCG.VN.

LCG.VN Daily Candlestick Chart
HUB.VN
50 minutes ago

I found you a Falling Three Methods Candle Pattern on the daily chart of HUB.VN.

HUB.VN Daily Candlestick Chart
HT1.VN
50 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HT1.VN.

HT1.VN Daily Candlestick Chart
HMC.VN
50 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HMC.VN.

HMC.VN Daily Candlestick Chart
HCD.VN
50 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HCD.VN.

HCD.VN Daily Candlestick Chart
GEX.VN
50 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GEX.VN.

GEX.VN Daily Candlestick Chart
FCM.VN
50 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FCM.VN.

FCM.VN Daily Candlestick Chart
DXG.VN
50 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DXG.VN.

DXG.VN Daily Candlestick Chart